{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T05:48:11Z","timestamp":1782193691627,"version":"3.54.5"},"reference-count":77,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T00:00:00Z","timestamp":1782172800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      Chronic atrophic gastritis (CAG) is an important precancerous lesion of gastric cancer, with\n                      <jats:italic>Helicobacter pylori<\/jats:italic>\n                      (\n                      <jats:italic>H. pylori<\/jats:italic>\n                      ) infection being a major etiological factor. Although quadruple therapy is the first-line treatment for\n                      <jats:italic>H. pylori<\/jats:italic>\n                      eradication, it still has certain limitations. The comparative efficacy of oral Chinese patent medicines combined with quadruple therapy remains unclear. Therefore, this study conducted a network meta-analysis (NMA) to systematically evaluate their efficacy and safety.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Randomized controlled trials (RCTs) on oral Chinese patent medicines combined with quadruple therapy for chronic atrophic gastritis were searched electronically in databases including China National Knowledge Infrastructure (CNKI), VIP, WanFang, Chinese Biomedical Literature Database (CBM), PubMed, Web of Science, and Cochrane Library from January 1, 2016, to April 1, 2026. Network Meta-analysis was performed on the included RCTs using Stata and R software.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      A total of 45 RCTs were included, involving 4,465 participants and 10 kinds of oral Chinese patent medicines. The network Meta-analysis showed that the 10 oral Chinese patent medicines (OCPMs) combined with quadruple therapy (QT) could effectively eradicate\n                      <jats:italic>H. pylori<\/jats:italic>\n                      eradication rates, improve gastrin and pepsinogen levels, and reduce inflammatory factor levels. The SUCRA ranking indicated that, Weisu granule combined with QT may be associated with greater benefit for improving\n                      <jats:italic>H. pylori<\/jats:italic>\n                      eradication rate, increasing motilin levels, and reducing interleukin-6 and tumor necrosis factor-\n                      <jats:italic>\u03b1<\/jats:italic>\n                      levels. Weifuchun tablets showed a favorable SUCRA ranking for increasing gastrin levels and reducing C-reactive protein and interleukin-8 levels. Moluo pills showed the highest SUCRA ranking for reducing interleukin-1\u03b2 levels, while Jinghua Weikang Capsule showed the highest SUCRA probability for improving pepsinogen I levels. In addition, Biling Weitong granule ranked highest by SUCRA for improving pepsinogen II levels and the pepsinogen I\/pepsinogen II ratio. However, these findings are based on indirect evidence and require confirmation in future head-to-head trials.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>\n                      Within the limitations of low-certainty evidence, the 10 oral Chinese patent medicines combined with quadruple therapy showed exploratory trends in improving\n                      <jats:italic>H. pylori<\/jats:italic>\n                      eradication rates, gastrin, pepsinogen, and inflammatory factor levels in patients with chronic atrophic gastritis, with few adverse reactions. However, the evidence network was predominantly star-shaped without closed loops, lacking direct head-to-head comparisons among different patent medicines. Restricted by the small sample size, methodological flaws and high clinical heterogeneity of included trials, the current findings should be regarded as hypothesis-generating rather than definitive clinical conclusions. Further large-sample, multicenter, high-quality randomized controlled trials are still required to verify our exploratory results and support precise clinical decision-making.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Systematic review registration<\/jats:title>\n                    <jats:p>\n                      <jats:ext-link>https:\/\/www.crd.york.ac.uk\/PROSPERO\/view\/CRD420261366962<\/jats:ext-link>\n                      , CRD420261366962.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fmed.2026.1859753","type":"journal-article","created":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T05:26:00Z","timestamp":1782192360000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Efficacy and safety of oral Chinese patent medicine combined with quadruple therapy for chronic atrophic gastritis: a systematic review and network meta-analysis"],"prefix":"10.3389","volume":"13","author":[{"given":"Dan","family":"Han","sequence":"first","affiliation":[{"name":"Department of Integrated Traditional Chinese and Western Medicine, Liaoning University of Traditional Chinese Medicine Xinglin College","place":["Shenyang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Yu","sequence":"additional","affiliation":[{"name":"Shenyang Second Traditional Chinese Medicine Hospital","place":["Shenyang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo-yi","family":"Wang","sequence":"additional","affiliation":[{"name":"Organization Department, Liaoning University of Traditional Chinese Medicine","place":["Shenyang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhan-ze","family":"Ma","sequence":"additional","affiliation":[{"name":"Department of Integrated Traditional Chinese and Western Medicine, Liaoning University of Traditional Chinese Medicine Xinglin College","place":["Shenyang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,6,23]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"339","DOI":"10.12290\/xhyxzz.2022-0374","article-title":"Research Progress on the relationship between Helicobacter Pylori associated chronic atrophic gastritis and gastric Cancer","volume":"14","author":"Wu","year":"2023","journal-title":"Med J Peking Union Medical College Hospital"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"148","DOI":"10.12677\/md.2025.152020","article-title":"Research Progress on the correlation between gastric xanthoma and early gastric Cancer and precancerous lesions","volume":"15","author":"Xia","year":"2025","journal-title":"Diagnosi"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1002\/ueg2.12507","article-title":"Prevalence and temporal trend of gastric preneoplastic lesions in Asia: a systematic review with meta-analysis","volume":"12","author":"Li","year":"2024","journal-title":"United European Gastroenterol J"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.11847\/zgggws2017-33-07-20","article-title":"Clinical characteristics of chronic atrophic gastritis patients in Heilongjiang province","volume":"33","author":"Wang","year":"2017","journal-title":"Chin J Public Health"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"230","DOI":"10.3969\/jissn1671-038X20250.04","article-title":"Expert consensus on integrated traditional Chinese and Western medicine diagnosis and treatment of chronic atrophic gastritis (2025)","volume":"33","year":"2025","journal-title":"Chin J Integr Trad West Med Dig"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"193","DOI":"10.13422\/j.cnki.syfjx.20231714","article-title":"Current status of outcome indicators in randomized controlled trials of traditional Chinese medicine for treating chronic atrophic gastritis","volume":"30","author":"Zhang","year":"2024","journal-title":"Chin J Exp Tradit Med Formulae"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"479","DOI":"10.3969\/j.issn.1671-038X.2023.06.16","article-title":"Advances in the pathogenesis of chronic atrophic gastritis","volume":"31","author":"Fu","year":"2023","journal-title":"Chin J Integr Trad West Med Dig"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"33","DOI":"10.3969\/j.issn1671-038X2014.01.012","article-title":"Combined detection of pepsinogen and gastrin in the diagnosis of chronic atrophic gastritis","volume":"22","author":"Yuan","year":"2014","journal-title":"Chin J Integr Trad West Med Dig"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"640","DOI":"10.3969\/j.issn.1671-038X.2018.08.03","article-title":"Clinical effects of Yangwei granules combined with quadruple therapy on helicobacter pylori positive chronic atrophic gastritis and its influence on gastrin, endothelin and pepsinogens","volume":"26","author":"Zhao","year":"2018","journal-title":"Chin J Integr Trad West Med Dig"},{"key":"ref10","first-page":"152","article-title":"Clinical study of Yangwei granules combined with quadruple therapy in the treatment of chronic atrophic gastritis with positive Hp","volume":"16","author":"Zhang","year":"2019","journal-title":"Chin Med Herald"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"171","DOI":"10.3969\/j.issn.1674-9308.2020.36.049","article-title":"Observation of the efficacy of Yangwei granule in the treatment of chronic atrophic gastritis with Hp infection","volume":"12","author":"Zhu","year":"2020","journal-title":"China Continuing Medical Education"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"130","DOI":"10.19435\/j.1672-1721.2023.25.042","article-title":"Clinical study on Yangwei granules combined with quadruple therapy for chronic atrophic gastritis complicated with Helicobacter pylori infection [J]","volume":"27","author":"Xiong","year":"2023","journal-title":"The Primary Medical Forum"},{"key":"ref13","first-page":"169","article-title":"Observation on the efficacy of Yangwei granules as adjuvant therapy in Helicobacter pylori (Hp)-positive chronic atrophic gastritis (CAG)","volume":"20","author":"Liu","year":"2023","journal-title":"Womens Health"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"115","DOI":"10.3969\/j.issn.2095-6851.2023.03.061","article-title":"Effect observation of Yangwei granules as adjuvant therapy for Helicobacter pylori-positive chronic atrophic gastritis","volume":"3","author":"Jia","year":"2023","journal-title":"Special Health"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"688","DOI":"10.3760\/cma.j.issn.1673-4246.2019.07.004","article-title":"Clinical study on treatment of chronic atrophic gastritis with Weisu granule combined with quadruple therapy","volume":"41","author":"Liang","year":"2019","journal-title":"Int J Traditional Chinese Medicine"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"43","DOI":"10.3969\/j.issn.1674-4721.2021.16.012","article-title":"Effect of Weisu granules combined with quadruple therapy in the treat-ment of Hp positive chronic atrophic gastritis of the spleen and stomachwith gas stagnation","volume":"28","author":"Qi","year":"2021","journal-title":"China Modern Med"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"281","DOI":"10.14009\/j.issn.1672-2124.2021.03.006","article-title":"Efficacy of Weisu granules combined with quadruple therapy in the treatment of HelicobacterPylori positive chronic atrophic gastritis","volume":"21","author":"Huang","year":"2021","journal-title":"Evaluation and analysis of drug-use in hospitals of China"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"1856","DOI":"10.13241\/j.cnki.pmb.2022.10.012","article-title":"Effect of Weisu granule combined with quadruple therapy on serum gastrointestinal hormone and gastric mucosal COX-2 and NF-\u03baB in patients with Hp positive chronic atrophic gastritis. Progress in modern","volume":"22","author":"Wang","year":"2022","journal-title":"Biomedicine"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"28","DOI":"10.3969\/j.issn.1006-1533.2023.20.008","article-title":"The value of Weisu granules combined with quadruple therapy in the treatment of chronic atrophic gastritis patients with helicobacter pylori positive. Shanghai","volume":"44","author":"Jin","year":"2023","journal-title":"Pharm J"},{"key":"ref20","first-page":"134","article-title":"Analysis of inflammatory factors of Weisu granules combined with quadruple therapy in chronic atrophic gastritis with Hp infection","volume":"12","author":"Zhang","year":"2024","journal-title":"Med Health"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"113","DOI":"10.3969\/j.issn.1006-1959.2025.16.023","article-title":"Observation on the curative effect of Weisu granules in the treatment of chronic atrophic Gastritisand its effect on serum inflammatory factors and gastrointestinal hormones","volume":"38","author":"Chen","year":"2025","journal-title":"Journal of Med Information"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"150","DOI":"10.3969\/j.issn.2095-7629.2020.15.109","article-title":"Clinical efficacy of Weifuchun combined with quadruple therapy in the treatment of chronic atrophic gastritis caused by Helicobacter pylori infection","volume":"18","author":"Ma","year":"2020","journal-title":"Contemporary Medical Symposium"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"178","DOI":"10.11966\/j.issn.2095-994X.2020.06.06.59","article-title":"Effects of Weifuchun tablets and esomeprazole on the levels of IL-6, IL-8 and TNF-\u03b1 in patients with chronic atrophic gastritis","volume":"6","author":"Wang","year":"2020","journal-title":"World Journal of Complex Medicine"},{"key":"ref24","first-page":"113","article-title":"Analysis of therapeutic efficiency and adverse reactions of quadruple therapy combined with Weifuchun in the treatment of chronic atrophic gastritis","volume":"20","author":"Munila","year":"2021","journal-title":"Women's Health Res China and Foreign Countries"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"22","DOI":"10.19296\/j.cnki.1008-2409.2021-03-006","article-title":"Efficacy of Weifuchun tablet combined with quadri-combination therapy of rabeprazole in the treatment of chronic atrophic gastritis patients complicated with Hp infection","volume":"34","author":"Wang","year":"2021","journal-title":"Acta Medicinae Sinica"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"956","DOI":"10.19381\/j.issn.1001-7585.2021.06.023","article-title":"The effect of Weifuchun combined with quadruple therapy on gastrointestinal hormones and immune function in patients with chronic atrophic gastritis","volume":"34","author":"Hu","year":"2021","journal-title":"J Med Theor Prac"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"85","DOI":"10.13457\/j.cnki.jncm.2024.06.016","article-title":"Clinical study on Weifuchun combined with bismuth quadruple therapy for atrophic gastritis complicated with Hp infection","volume":"56","author":"Wang","year":"2024","journal-title":"New Chinese Med"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"67","DOI":"10.19621\/j.cnki.11-3555\/r.2019.1237","article-title":"Clinical observation of Morodan combined with quadruple therapy in the treatment of Helicobacter Pylori-positive chronic atrophic gastritis","volume":"27","author":"Xiao","year":"2019","journal-title":"China's Naturopathy"},{"key":"ref29","first-page":"623","article-title":"Control effect of Moluodan combined with rabeprazole quadruple therapy on Hp-positive chronic atrophic gastritis","volume":"19","author":"Wang","year":"2020","journal-title":"Chin J of public Health Eng"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"131","DOI":"10.14033\/j.cnki.cfmr.2024.20.033","article-title":"Effect of Moluodan combined with quadruple therapy in the treatment of Helicobacter Pylori-related chronic atrophic gastritis","volume":"22","author":"Chen","year":"2024","journal-title":"Chinese and Foreign Medical Res"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"33","DOI":"10.13457\/j.cnki.jncm.2024.03.007","article-title":"Clinical study on Moluo pellets combined with quadruple therapy for Helicobacter Pylori-positive chronic atrophic gastritis","volume":"56","author":"Li","year":"2024","journal-title":"New Chinese medicine"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"93","DOI":"10.3969\/j.issn.2096-3327.2025.05.015","article-title":"Efficacy of Morodan combined with bismuth-containing quadruple therapy for Helicobacter Pylori-positive chronic atrophic gastritis","volume":"22","author":"Shang","year":"2025","journal-title":"Chinese Journal of Rational Drug Use Exploration"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"9","DOI":"10.3969\/j.issn.1674-4985.2025.12.003","article-title":"The application effect of Moluodan + modified quadruple sequential therapy in Hp-positive chronic atrophic gastritis","volume":"22","author":"Wu","year":"2025","journal-title":"Med Innovation of China"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.3969\/j.issn.2095-8552.2018.09.038","article-title":"Clinical observation of Zhizhu Kuanzhong capsules combined with western medicine in the treatment of Helicobacter pylori-positive chronic atrophic gastritis","volume":"46","author":"Li","year":"2018","journal-title":"Chinese Journal of Clinicians"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"429","DOI":"10.13381\/j.cnki.cjm.201904011","article-title":"Clinical effect of Zhizhu Kuanzhong capsules combined with probiotics on Helicobacter pylori-positive elderly patients with chronic atrophic gastritis","volume":"31","author":"Li","year":"2019","journal-title":"Chin J Microeco"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"65","DOI":"10.16040\/j.cnki.cn15-1101.2020.11.040","article-title":"Clinical observation of Zhizhu Kuanzhong capsules combined with Western medicine in the treatment of Helicobacter Pylori-positive chronic atrophic gastritis","volume":"39","author":"Li","year":"2020","journal-title":"Inner Mongolia J Traditional Chinese Med"},{"key":"ref37","first-page":"121","article-title":"Observation on the effect of Zhizhu Kuanzhong capsules combined with quadruple therapy in the treatment of elderly patients with Hp-positive chronic atrophic gastritis","volume":"8","author":"Liu","year":"2022","journal-title":"Women's Health Research"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"485","DOI":"10.3969\/j.issn.1674-4659.2022.04.0485","article-title":"Effect of quadruple therapy combined with Jinghua Weikang in the treatment of Hp-positive chronic atrophic gastritis","volume":"29","author":"Guan","year":"2022","journal-title":"Clinical Medical Engineering"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"626","DOI":"10.11713\/j.issn.1009-4822.2023.05.012","article-title":"Effect of quadruple therapy combined with Jinghua Weikang in the treatment of Hp-positive chronic atrophic gastritis","volume":"24","author":"Ni","year":"2023","journal-title":"Journal of Beihua University (Natural Science)"},{"key":"ref40","doi-asserted-by":"publisher","first-page":"222","DOI":"10.13898\/j.cnki.issn.1000-2200.2023.02.020","article-title":"Effect of standard quadruple combined with Jinghua Weikang capsule on the levels of serum gastrin 17 and PG, and immune function in chronic atrophic gastritis patients with positive Hp","volume":"48","author":"Li","year":"2023","journal-title":"J Bengbu Med Coll"},{"key":"ref41","doi-asserted-by":"publisher","first-page":"1567","DOI":"10.3969\/j.issn.1004-2814.2025.08.019","article-title":"Observation on the efficacy of Jinghua Weikang capsules as adjuvant therapy in the treatment of chronic atrophic gastritis","volume":"41","author":"Li","year":"2025","journal-title":"Journal of practical traditional Chinese medicine"},{"key":"ref42","first-page":"49","article-title":"Treatment of 41 cases of chronic atrophic gastritis with Qi stagnation and blood stasis syndrome by Biling Weitong granules","volume":"51","author":"Lu","year":"2020","journal-title":"Jiangxi Journal of Traditional Chinese Medicine"},{"key":"ref43","first-page":"122","article-title":"Effect of Biling Weitong granules combined with quadruple therapy on chronic atrophic gastritis with positive Helicobacter pylori infection","volume":"18","author":"Hong","year":"2021","journal-title":"China Medical Herald"},{"key":"ref44","doi-asserted-by":"publisher","first-page":"692","DOI":"10.3969\/j.issn.1008-8849.2023.05.022","article-title":"Biling Weitong granules combined with quadruple therapy in the treatment of chronic atrophic gastritis complicated with Helicobacter pylori infection: efficacy and its effect on serum levels of inflammatory factors, EGF and TGF-\u03b21","volume":"32","author":"Su","year":"2023","journal-title":"Modern Journal of Integrated Traditional Chinese and Western Medicine"},{"key":"ref45","doi-asserted-by":"publisher","first-page":"1832","DOI":"10.13935\/j.cnki.sjzx.240923","article-title":"Clinical efficacy of Biling Weitong granules combined with quadruple therapy in treating Helicobacter Pylori-positive chronic atrophic gastritis patients and its protective effect on gastric mucosa","volume":"19","author":"Gong","year":"2024","journal-title":"World Journal of Integrated Traditional and Western Medicine"},{"key":"ref46","doi-asserted-by":"publisher","first-page":"1916","DOI":"10.13359\/j.cnki.gzxbtcm.2023.08.010","article-title":"Efficacy of Wumei pills combined with anti-Hp quadruple eradication therapy for the treatment of Hp-infected chronic atrophic gastritis of cold-heat concurrence type and their effect on Hp eradication rate and serum levels of IL-1\u03b2 and IL-6","volume":"40","author":"Sun","year":"2023","journal-title":"J Guangzhou University of Traditional Chinese Medicine"},{"key":"ref47","doi-asserted-by":"publisher","first-page":"1977","DOI":"10.3969\/j.issn.1002-2619.2024.12.009","article-title":"Clinical efficacy of Wumei pill for helicobacter pylori positive chronic atrophic gastritis of cold and heat miscellaneous type","volume":"46","author":"Mao","year":"2024","journal-title":"Hebei J Tradit Chin Med"},{"key":"ref48","doi-asserted-by":"publisher","first-page":"49","DOI":"10.3969\/j.issn.1002-8714.2025.13.017","article-title":"Effect of Wumei pills combined with quadruple therapy on Hp eradication rate and inflammatory indexes in patients with Hp-positive chronic atrophic gastritis","volume":"13","author":"Zhao","year":"2025","journal-title":"Health Friend"},{"key":"ref49","volume-title":"Clinical Observation of Sanqi Shengweipill Combined with Quadruple Therapyin the Treatment of Chronic Atrophicgastritis Caused by Hp Infection","author":"Huang","year":"2023"},{"key":"ref50","first-page":"078","article-title":"Effect analysis of clinical efficacy of Sanqi Shengwei pills combined with quadruple therapy in the treatment of chronic atrophic gastritis with Hp infection","volume":"8","author":"Zeng","year":"2024","journal-title":"Med Health"},{"key":"ref51","author":"Huang","year":"2025"},{"key":"ref52","doi-asserted-by":"publisher","first-page":"62","DOI":"10.3969\/j.issn.1007-614x.2019.11.062","article-title":"Clinical observation on the effect of Kangfuxin liquid combined with killing Helicobacter pylori on chronic atrophic gastritis","volume":"35","author":"Sheng","year":"2019","journal-title":"Chinese Community Doctors"},{"key":"ref53","doi-asserted-by":"publisher","first-page":"59","DOI":"10.13457\/j.cnki.jncm.2020.04.018","article-title":"Clinical study on Kangfuxin liquid combined with quadruple therapy for Helicobacter Pylori positive chronic atrophic gastritis","volume":"52","author":"Zhao","year":"2020","journal-title":"J New Chinese Medicine"},{"key":"ref54","doi-asserted-by":"publisher","first-page":"e1003082","DOI":"10.1371\/journal.pmed.1003082","article-title":"CINeMA: an approach for assessing confidence in the results of a network meta-analysis","volume":"17","author":"Nikolakopoulou","year":"2020","journal-title":"PLoS Med"},{"key":"ref55","doi-asserted-by":"publisher","first-page":"e1080","DOI":"10.1002\/cl2.1080","article-title":"CINeMA: software for semi automated assessment of the confidence in the results of network meta-analysis","volume":"16","author":"Papakonstantinou","year":"2020","journal-title":"Campbell Syst Rev"},{"key":"ref56","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.7507\/1672-2531.202002172","article-title":"Rating the certainty of evidence from network meta-analysis: an introduction to CINeMA","volume":"20","author":"Wang","year":"2020","journal-title":"Chin J Evid Based Med"},{"key":"ref57","doi-asserted-by":"publisher","first-page":"149","DOI":"10.3969\/j.issn.1008-7125.2023.03.004","article-title":"Guidelines for diagnosis and treatment of chronic gastritis in China (2022, Shanghai)","volume":"28","author":"Fang","year":"2023","journal-title":"Chin J Gastroenterol"},{"key":"ref58","doi-asserted-by":"publisher","first-page":"1513426","DOI":"10.3389\/fcell.2024.1513426","article-title":"Current study of pathogen etic mechanisms and therapeutics of chronic atrophic gastritis: a comprehensive review","volume":"12","author":"Kuang","year":"2024","journal-title":"Front Cell Dev Biol"},{"key":"ref59","doi-asserted-by":"publisher","first-page":"20745","DOI":"10.1038\/s41598-023-48088-3","article-title":"Therapeutic effects and potential mechanisms of endoscopic submucosal injection of mesenchymal stem cells on chronic atrophic gastritis","volume":"13","author":"Xu","year":"2023","journal-title":"Sci Rep"},{"key":"ref60","doi-asserted-by":"publisher","first-page":"1699501","DOI":"10.3389\/fimmu.2025.1699501","article-title":"The oral-gut axis in chronic atrophic gastritis: current perspectives and integrated strategies","volume":"16","author":"Zha","year":"2026","journal-title":"Front Immunol"},{"key":"ref61","first-page":"185","article-title":"Research progress on the mechanism of traditional Chinese medicine in the treatment of chronic atrophic gastritis","volume":"31","author":"Lin","year":"2024","journal-title":"China modern medicine"},{"key":"ref62","doi-asserted-by":"publisher","first-page":"627","DOI":"10.3969\/j.issn.1671-038X.2024.07.16","article-title":"Research progress on experimental mechanism of traditional Chinese medicine treatment of chronicatrophicgastritis","volume":"32","author":"Suo","year":"2024","journal-title":"Chin J Integr Trad West Med Dig"},{"key":"ref63","doi-asserted-by":"publisher","first-page":"730","DOI":"10.3969\/j.issn.1671-038X.2024.08.18","article-title":"Research progress of mechanism about Jinghua Weikang capsule against Helicobacterpylori","volume":"32","author":"Wei","year":"2024","journal-title":"Chin J Integr Trad West Med Dig"},{"key":"ref64","doi-asserted-by":"publisher","first-page":"144","DOI":"10.12173\/j.issn.2097-4922.202404140","article-title":"Research progress in the treatment of Helicobacter pylori infection with traditional Chinese medicine","volume":"28","author":"Liu","year":"2024","journal-title":"Yaoxue QianYan Zazhi"},{"key":"ref65","first-page":"515","article-title":"Efficacy of Bilin Weitong granules combined with lansoprazole quadruple therapy in patients with chronic gastritis complicated with Helicobacter pylori infection","volume":"25","author":"Dai","year":"2020","journal-title":"Modern Digestion Intervention"},{"key":"ref66","doi-asserted-by":"publisher","first-page":"1554","DOI":"10.12677\/jcpm.2024.34223","article-title":"Research progress on traditional Chinese medicine regulating signaling pathways related to chronic atrophic gastritis","volume":"3","author":"Liu","year":"2024","journal-title":"J Clin Personalized Med"},{"key":"ref67","doi-asserted-by":"publisher","first-page":"478","DOI":"10.20053\/j.issn1001-5094.202503100100","article-title":"Observation on effect of Weifuchun combined with Teprenone on patients with chronic atrophic Gastritisand intestinal metaplasia","volume":"49","author":"Yu","year":"2025","journal-title":"Progress in Pharmaceutical Sci"},{"key":"ref68","doi-asserted-by":"publisher","first-page":"563","DOI":"10.12677\/tcm.2024.133087","article-title":"Research progress on clinical application of Weifuchun based on TCM \"treating different diseases with the same method\"","volume":"13","author":"Chen","year":"2024","journal-title":"J Tradit Chin Med"},{"key":"ref69","doi-asserted-by":"publisher","first-page":"823","DOI":"10.12173\/j.issn.1004-4337.202408182","article-title":"Moluodan concentrated pill in the treatment of chronic atrophic gastritis through the TNF\/PI3K\/AKT signaling pathway","volume":"37","author":"Chen","year":"2024","journal-title":"J Mathematical Med"},{"key":"ref70","doi-asserted-by":"publisher","first-page":"255","DOI":"10.13193\/j.issn.1673-7717.2024.09.049","article-title":"Project team of expert consensus on the clinical application of Yangwei granules in the treatment of chronic atrophic gastritis. Expert consensus on clinical application of Yangwei granules in treatment of chronic atrophic gastritis","volume":"42","year":"2024","journal-title":"Chin Arch Tradit Chin Med"},{"key":"ref71","doi-asserted-by":"publisher","first-page":"70","DOI":"10.13457\/j.cnki.jncm.2020.12.021","article-title":"Clinical study on Yangwei granules for chronic atrophic gastritis with spleen Deficiency and Qi stagnation syndrome","volume":"52","author":"Huang","year":"2020","journal-title":"J New Chinese Med"},{"key":"ref72","doi-asserted-by":"publisher","first-page":"678","DOI":"10.12173\/j.issn.1005-0698.202402031","article-title":"Efficacy and safety of Kangfuxin liquid in postoperative gastrointestinal endoscopy patients: a meta-analysis","volume":"33","author":"Zhao","year":"2024","journal-title":"Yaowu Liuxingbingxue Zazhi"},{"key":"ref73","doi-asserted-by":"publisher","first-page":"1308","DOI":"10.13288\/j.11-2166\/r.2019.15.011","article-title":"A multi-center, randomize-controlled clinical trial of Kangfuxin solution for patients with chronic skin ulcer","volume":"60","author":"Chen","year":"2019","journal-title":"J Tradit Chin Med"},{"key":"ref74","doi-asserted-by":"publisher","first-page":"125","DOI":"10.19347\/j.cnki.2096-1413.202409031","article-title":"Effects of Zhizhu Kuanzhong capsules combined with mosapride on gastrointestinal hormones and gastric emptying in patients with functional dyspepsia of spleen deficiency and Qi stagnation","volume":"9","author":"Liu","year":"2024","journal-title":"Clinical Res Pract"},{"key":"ref75","first-page":"721","article-title":"Effect of Zhizhu Kuanzhong capsules on patients with functional dyspepsia complicated with anxiety and depression","volume":"46","author":"Hou","year":"2019","journal-title":"J Int Psychiatry"},{"key":"ref76","doi-asserted-by":"publisher","first-page":"272","DOI":"10.3969\/j.issn.1671-038X.2021.04.09","article-title":"Clinical effect of Weisu granules combined with domperidone on patients with functional dyspepsia with the syndrome of liver-stomach disharmony and effect of gastrointestinal hormone","volume":"29","author":"Liang","year":"2021","journal-title":"Chin J Integr Trad West Med Dig"},{"key":"ref77","first-page":"050","article-title":"Clinical observation on the efficacy of Weisu granules in the treatment of chronic gastritis","volume":"5","author":"Zhao","year":"2025","journal-title":"J Health Medicine, Chinese Science and Technology Journal Database"}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2026.1859753\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T05:26:51Z","timestamp":1782192411000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2026.1859753\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,23]]},"references-count":77,"alternative-id":["10.3389\/fmed.2026.1859753"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2026.1859753","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,23]]},"article-number":"1859753"}}